By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Caliper Life Sciences and Genomic Health rose 30 percent each during November, as the GenomeWeb Daily News Index outperformed the broader market.

Overall, 15 of the 33 stocks in the GWDN Index rose for the month. The Index finished November up 2 percent, while the Dow Jones Industrial Average was down 1 percent, the Nasdaq was virtually flat, and the Nasdaq Biotech Index slipped 2 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.